Biobanking Market

Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) - Global Forecast to 2022

Report Code: BT 1224 Aug, 2017, by marketsandmarkets.com

[164 Pages Report] According to new research report, Biobanking Market is expected to reach $2.69 billion by 2022 from $1.72 billion in 2016 at a CAGR of 7.8%. The base year for this study is 2016. The equipment segment is estimated to account for the largest share of the market in 2017. This is primarily attributed to the increasing number of biobanks and rising number of biosamples around the world, due to which the demand for equipment remains high.

Market Dynamics

Drivers

  • Increase in Genomic Research Activities for Studying Diseases
  • Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns
  • Government and Private Funding to Support Regenerative Medicine Research
  • Growing Need for Cost-Effective Drug Discovery and Development

Restraints

  • High Cost of Automation
  • Issues Related to Biospecimen Sample Procurement

Opportunities

  • Emerging Countries
  • Growing Focus on the R&D of Cell Therapies

Challenges

  • Long-Term Sustainability of Biobanks

Regenerative medicine application of biobanking will drive the market

Biobanking plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses. Growth in the number of research activities in this segment forms a major driver for the  market. The availability of government funding for regenerative medicine, stem cell therapeutics, and cell & gene therapy is supporting research activities in this segment. Apart from this, the increasing trend of cord blood banking will also aid growth of this market segment. Future prospects including advancements in orthopedic procedures with the use of stem cells are expected to further support market growth for regenerative medicine.

The objectives of this study are as follows:

  • To define, describe, and forecast the market by product and service, sample type, storage type, application, and region
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
  • To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
  • To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies
  • To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product launches in the market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by product and service, sample type, storage type, application, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources have been used to identify and collect information useful for this extensive commercial study of the market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The breakdown of profiles of primaries is shown in the figure below:

Biobanking Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the biobanking market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)],  Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands), LVL Technologies GmbH & Co. KG (Germany), Panasonic Healthcare Holdings Co. Ltd (Japan), Greiner Bio One [Greiner Holding AG, Austria)], Biokryo GmbH (Germany), Biobank AS (Norway), Biorep Technologies Inc. (U.S.), Cell & Co Bioservices (France), RUCDR infinite biologics (U.S.), Modul-Bio (France), CSols Ltd (U.K.), Ziath (U.K.), and LabVantage Solutions Inc. (U.S.)

Target Audience for this Report:

  • Biobanking associations
  • Research & consulting firms
  • Distributors of research products
  • Contract manufacturers of biobanking equipment and consumables
  • Research institutes and clinical research organizations (CROs)
  • Venture capitalists
  • Government associations

Major Market Developments

  • In 2017, Brooks Automation, Inc. (U.S.) launched BioStore IIIv, BioStudies Biobank Data Management, FluidX, IntelliXcap Decapper systems to strengthen its product portfolio in biobanking segment.
  • In 2016, Thermo Fisher Scientific Inc. (U.S.) entered into a partnership with Hamilton Storage (U.S.) to strengthened Thermo Fisher’s presence in the market.
  • In 2015, Panasonic Healthcare Holdings (Japan) launched MDF-DU900V VIP -86°C Upright Freezer.

Scope of the Report:

This report categorizes the biobanking market into the following segments:

Biobanking Market By Product and Service

  • Equipment
  • Consumables
  • Services
  • Software

Biobanking Market By Sample Type

  • Blood Products
  • Human Tissues
  • Nucleic Acids
  • Cell Lines
  • Biological Fluids
  • Human Waste Products

Biobanking Market By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

Biobanking Market By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

A number of factors such as increasing number of genomics research activities for studying diseases, advances in biobanking and growing trend of conserving cord blood stem cells of newborns and government & private funding to support regenerative medicine research in biobanking are expected to drive the growth of this market.

The global market is segmented by product and service, sample type, storage type, application and regions. By product and service, the market is segmented into equipment, consumables, services and software. The equipment segment is expected to lead the global market in 2017. Factors such as the growth in the number of biobanks and number of biosamples to be stored are increasing the demand for biobanking equipment.

By sample type, the market is classified into blood products, human tissues, cell lines, nucleic acids, human waste products, and biological fluids. Since blood and blood products are the most collected specimens and are used as a source of DNA and RNA, this segment type holds the largest share of the market.

On the basis of applications, the market is segmented into regenerative medicine, life science research, and clinical research. Regenerative Medicine is expected to account for the largest share of the market in 2017 on the basis of applications. Growing research in regenerative medicine and the increasing demand for well characterized and quality biosamples for research are prime reasons for the growth of this market segment.

By storage type, the market is segmented into manual storage and automated storage. In 2017, the manual storage segment is estimated to account for the largest share and the automated storage segment is projected to grow at the highest CAGR during the forecast period.

Biobanking Market

The global market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. Improving life sciences research infrastructure in emerging economies and growing government investment in biomedical, pharmaceutical, and biotechnology industries are some of the factors propelling market growth in the Asia-Pacific region.

The high cost of automation and issues related to biospecimen sample procurement are expected to restrain the market growth to a certain extent.

Regenerative medicine and life science research application will drive the growth of biobanking market

Regenerative Medicine

Regenerative medicine is the process of creating living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. The archiving of biological specimens from donors for use in research has become an important resource for regenerative medicine research. High-quality and well-annotated tissue sample collections stored in dedicated biorepositories have become an essential tool in regenerative medicine for developing diagnostic, prognostic, and therapeutic applications to advance human health.

Life Science Research

In-house laboratories, repositories, and biobanks require primary cell cultures and cell lines for biomedical research, personalized medicine, cell-based research, and related segments. Due to the large turnover of highly sensitive samples in these research activities, it is critical to have a repository for the proper handling of samples. A biosample repository ensures appropriate long-term storage conditions for such samples. The samples are sorted, tracked, and made available to scientists to support life science research activities. A dedicated biobank helps curtail the recurring cost of continuous sample procurement from donor sites, thereby supporting targeted research in life sciences.

Critical questions the report answers:

  • Where will all these developments take the industry in the mid to long term?
  • What are the upcoming industry applications for biobanking?

High cost of automation is a major factor restraining the growth of the market. Biospecimen storage instruments are equipped with advanced features and functionalities and are thus priced at a premium. Moreover, since the cost of biobanking operations are not limited to automation, organizations have to consider various factors on which their overall financial stability is dependent before moving towards automation. This, in turn, is creating challenges for the long-term sustainability of biobanks.

Major industry players launched innovative products to maintain and improve their position in the biobanking market. Hamilton Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Brooks Automation (U.S.), and Panasonic Healthcare Holdings Co. Ltd (Japan) have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Secondary Data
    2.2 Primary Data
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 29)
    4.1 Global Biobanking: Market Overview
    4.2 Geographic Analysis: Biobanking Market, By Region and Sample Type
    4.3 Global Biobanking Market, By Product & Service
    4.4 Geographical Snapshot of Global Biobanking Market

5 Market Overview (Page No. - 32)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increase in Genomic Research Activities for Studying Diseases
                    5.2.1.2 Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns
                    5.2.1.3 Government and Private Funding to Support Regenerative Medicine Research
                    5.2.1.4 Growing Need for Cost-Effective Drug Discovery and Development
           5.2.2 Restraints
                    5.2.2.1 High Cost of Automation
                    5.2.2.2 Issues Related to Biospecimen Sample Procurement
           5.2.3 Opportunities
                    5.2.3.1 Emerging Countries
                    5.2.3.2 Growing Focus on the R&D of Cell Therapies
           5.2.4 Challenges
                    5.2.4.1 Long-Term Sustainability of Biobanks

6 Global Biobanking Market, By Product & Service (Page No. - 39)
    6.1 Introduction
    6.2 Equipment
           6.2.1 Storage Equipment
           6.2.2 Sample Analysis Equipment
           6.2.3 Sample Processing Equipment
           6.2.4 Sample Transport Equipment
    6.3 Consumables
           6.3.1 Storage Consumables
           6.3.2 Analysis Consumables
           6.3.3 Processing Consumables
           6.3.4 Collection Consumables
    6.4 Services
           6.4.1 Storage Services
           6.4.2 Processing Services
           6.4.3 Transport Services
           6.4.4 Supply Services
    6.5 Software

7 Global Biobanking Market, By Sample Type (Page No. - 53)
    7.1 Introduction
    7.2 Blood Products
    7.3 Human Tissues
    7.4 Cell Lines
    7.5 Nucleic Acids
    7.6 Biological Fluids
    7.7 Human Waste Products

8 Global Biobanking Market, By Storage Type (Page No. - 60)
    8.1 Introduction
    8.2 Manual Storage
    8.3 Automated Storage

9 Global Biobanking Market, By Application (Page No. - 64)
    9.1 Introduction
    9.2 Regenerative Medicine
    9.3 Life Science Research
    9.4 Clinical Research

10 Global Biobanking Market, By Region (Page No. - 69)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Italy
             10.3.5 Netherlands
             10.3.6 Rest of Europe (RoE)
     10.4 APAC
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 South Korea
             10.4.5 Australia
             10.4.6 Rest of APAC (RoAPAC)
     10.5 RoW

11 Competitive Landscape (Page No. - 118)
     11.1 Introduction
     11.2 Market Share Analysis
     11.3 Competitive Leadership Mapping
             11.3.1 Visionary Leaders
             11.3.2 Innovators
             11.3.3 Dynamic Differentiators
             11.3.4 Emerging Companies
     11.4 Competitive Benchmarking
             11.4.1 Strength of Product Portfolio
             11.4.2 Business Strategy Excellence

12 Company Profiles (Page No. - 123)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Thermo Fisher Scientific Inc.
     12.2 Panasonic Healthcare Holdings Co., Ltd.
     12.3 Becton, Dickinson and Company
     12.4 Qiagen N.V.
     12.5 Merck KGaA
     12.6 VWR Corporation
     12.7 Tecan Trading AG
     12.8 Brooks Automation, Inc.
     12.9 Chart Industries, Inc.
     12.10 Hamilton Company
     12.11 Greiner Holding AG
     12.12 Promega Corporation

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 155)
     13.1 Industry Insights
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT : Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (123 Tables)

Table 1 Global Biobanking: Market Snapshot
Table 2 Global Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 3 Biobanking Equipment Market, By Region, 2015–2022 (USD Million)
Table 4 Biobanking Equipment Market, By Type, 2015–2022 (USD Million)
Table 5 Storage Equipment Market, By Region, 2015–2022 (USD Million)
Table 6 Sample Analysis Equipment Market, By Region, 2015–2022 (USD Million)
Table 7 Sample Processing Equipment Market, By Region, 2015–2022 (USD Million)
Table 8 Sample Transport Equipment Market, By Region, 2015–2022 (USD Million)
Table 9 Biobanking Consumables Market, By Region, 2015–2022 (USD Million)
Table 10 Biobanking Consumables Market, By Type, 2015–2022 (USD Million)
Table 11 Storage Consumables Market, By Region, 2015–2022 (USD Million)
Table 12 Analysis Consumables Market, By Region, 2015–2022 (USD Million)
Table 13 Processing Consumables Market, By Region, 2015–2022 (USD Million)
Table 14 Collection Consumables Market, By Region, 2015–2022 (USD Million)
Table 15 Biobanking Services Market, By Region, 2015–2022 (USD Million)
Table 16 Biobanking Services Market, By Type, 2015–2022 (USD Million)
Table 17 Storage Services Market, By Region, 2015–2022 (USD Million)
Table 18 Processing Services Market, By Region, 2015–2022 (USD Million)
Table 19 Transport Services Market, By Region, 2015–2022 (USD Million)
Table 20 Supply Services Market, By Region, 2015–2022 (USD Million)
Table 21 Biobanking Software Market, By Region, 2015–2022 (USD Million)
Table 22 Global Market, By Sample Type, 2015–2022 (USD Million)
Table 23 Biobanking Market for Blood Products, By Region, 2015–2022 (USD Million)
Table 24 Biobanking Market for Human Tissues, By Region, 2015–2022 (USD Million)
Table 25 Biobanking Market for Cell Lines, By Region, 2015–2022 (USD Million)
Table 26 Biobanking Market for Nucleic Acids, By Region, 2015–2022 (USD Million)
Table 27 Biobanking Market for Biological Fluids, By Region, 2015–2022 (USD Million)
Table 28 Biobanking Market for Human Waste Products, By Region, 2015–2022 (USD Million)
Table 29 Global Market, By Storage Type, 2015–2022 (USD Million)
Table 30 Biobanking Market for Manual Storage, By Region, 2015–2022 (USD Million)
Table 31 Biobanking Market for Automated Storage, By Region, 2015–2022 (USD Million)
Table 32 Global Market, By Application, 2015–2022 (USD Million)
Table 33 Biobanking Market for Regenerative Medicine Applications, By Region, 2015–2022 (USD Million)
Table 34 Biobanking Market for Life Science Research Applications, By Region, 2015–2022 (USD Million)
Table 35 Biobanking Market for Clinical Research Applications, By Region, 2015–2022 (USD Million)
Table 36 Global Market, By Region, 2015–2022 (USD Million)
Table 37 North America: Market, By Country, 2015–2022 (USD Million)
Table 38 North America: Market, By Product & Service, 2015–2022 (USD Million)
Table 39 North America: Biobanking Equipment Market, By Equipment Type, 2015–2022 (USD Million)
Table 40 North America: Biobanking Consumables Market, By Consumables Type, 2015–2022 (USD Million)
Table 41 North America: Biobanking Services Market, By Services Type, 2015–2022 (USD Million)
Table 42 North America: Market, By Sample Type, 2015–2022 (USD Million)
Table 43 North America: Market, By Storage Type, 2015–2022 (USD Million)
Table 44 North America: Market, By Application, 2015–2022 (USD Million)
Table 45 U.S.: Market, By Product & Service, 2015–2022 (USD Million)
Table 46 U.S.: Market, By Sample Type, 2015–2022 (USD Million)
Table 47 U.S.: Market, By Storage Type, 2015–2022 (USD Million)
Table 48 U.S.: Market, By Application, 2015–2022 (USD Million)
Table 49 Canada: Market, By Product & Service, 2015–2022 (USD Million)
Table 50 Canada: Market, By Sample Type, 2015–2022 (USD Million)
Table 51 Canada: Market, By Storage Type, 2015–2022 (USD Million)
Table 52 Canada: Market, By Application, 2015–2022 (USD Million)
Table 53 Europe: Market, By Country, 2015–2022 (USD Million)
Table 54 Europe: Market, By Product & Service, 2015–2022 (USD Million)
Table 55 Europe: Biobanking Equipment Market, By Equipment Type, 2015–2022 (USD Million)
Table 56 Europe: Biobanking Consumables Market, By Consumables Type, 2015–2022 (USD Million)
Table 57 Europe: Biobanking Services Market, By Services Type, 2015–2022 (USD Million)
Table 58 Europe: Market, By Sample Type 2015–2022 (USD Million)
Table 59 Europe: Market, By Storage Type, 2015–2022 (USD Million)
Table 60 Europe: Market, By Application, 2015–2022 (USD Million)
Table 61 Germany: Market, By Product & Service, 2015–2022 (USD Million)
Table 62 Germany: Market, By Sample Type, 2015–2022 (USD Million)
Table 63 Germany: Market, By Storage Type, 2015–2022 (USD Million)
Table 64 Germany: Market, By Application, 2015–2022 (USD Million)
Table 65 France: Market, By Product & Service, 2015–2022 (USD Million)
Table 66 France: Market, By Sample Type, 2015–2022 (USD Million)
Table 67 France: Market, By Storage Type, 2015–2022 (USD Million)
Table 68 France: Market, By Application, 2015–2022 (USD Million)
Table 69 U.K.: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 70 U.K.: Market, By Sample Type, 2015–2022 (USD Million)
Table 71 U.K.: Market, By Storage Type, 2015–2022 (USD Million)
Table 72 U.K.: Market, By Application, 2015–2022 (USD Million)
Table 73 Italy: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 74 Italy: Market, By Sample Type, 2015–2022 (USD Million)
Table 75 Italy: Market, By Storage Type, 2015–2022 (USD Million)
Table 76 Italy: Market, By Application, 2015–2022 (USD Million)
Table 77 Netherlands: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 78 Netherlands: Market, By Sample Type, 2015–2022 (USD Million)
Table 79 Netherlands: Market, By Storage Type, 2015–2022 (USD Million)
Table 80 Netherlands: Market, By Application, 2015–2022 (USD Million)
Table 81 RoE: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 82 RoE: Market, By Sample Type, 2015–2022 (USD Million)
Table 83 RoE: Market, By Storage Type, 2015–2022 (USD Million)
Table 84 RoE: Market, By Application, 2015–2022 (USD Million)
Table 85 APAC: Biobanking Market, By Country, 2015–2022 (USD Million)
Table 86 APAC: Market, By Product & Service, 2015–2022 (USD Million)
Table 87 APAC: Biobanking Equipment Market, By Equipment Type, 2015–2022 (USD Million)
Table 88 APAC: Biobanking Consumables Market, By Consumables Type, 2015–2022 (USD Million)
Table 89 APAC: Biobanking Services Market, By Services Type, 2015–2022 (USD Million)
Table 90 APAC: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 91 APAC: Market, By Storage Type, 2015–2022 (USD Million)
Table 92 APAC: Market, By Application, 2015–2022 (USD Million)
Table 93 China: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 94 China: Market, By Sample Type, 2015–2022 (USD Million)
Table 95 China: Market, By Storage Type, 2015–2022 (USD Million)
Table 96 China: Market, By Application, 2015–2022 (USD Million)
Table 97 Japan: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 98 Japan: Market, By Sample Type, 2015–2022 (USD Million)
Table 99 Japan: Market, By Storage Type, 2015–2022 (USD Million)
Table 100 Japan: Market, By Application, 2015–2022 (USD Million)
Table 101 India: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 102 India: Market, By Sample Type, 2015–2022 (USD Million)
Table 103 India: Market, By Storage Type, 2015–2022 (USD Million)
Table 104 India: Market, By Application, 2015–2022 (USD Million)
Table 105 South Korea: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 106 South Korea: Market, By Sample Type, 2015–2022 (USD Million)
Table 107 South Korea: Market, By Storage Type, 2015–2022 (USD Million)
Table 108 South Korea: Market, By Application, 2015–2022 (USD Million)
Table 109 Australia: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 110 Australia: Market, By Sample Type, 2015–2022 (USD Million)
Table 111 Australia: Market, By Storage Type, 2015–2022 (USD Million)
Table 112 Australia: Market, By Application, 2015–2022 (USD Million)
Table 113 RoAPAC: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 114 RoAPAC: Market, By Sample Type, 2015–2022 (USD Million)
Table 115 RoAPAC: Market, By Storage Type, 2015–2022 (USD Million)
Table 116 RoAPAC: Market, By Application, 2015–2022 (USD Million)
Table 117 RoW: Biobanking Market, By Product & Service, 2015–2022 (USD Million)
Table 118 RoW: Biobanking Equipment Market, By Equipment Type, 2015–2022 (USD Million)
Table 119 RoW: Biobanking Consumables Market, By Consumables Type, 2015–2022 (USD Million)
Table 120 RoW: Biobanking Services Market, By Services Type, 2015–2022 (USD Million)
Table 121 RoW: Biobanking Market, By Sample Type, 2015–2022 (USD Million)
Table 122 RoW: Market, By Storage Type, 2015–2022 (USD Million)
Table 123 RoW: Market, By Application, 2015–2022 (USD Million)
 
 
List of Figures (38 Figures)
 
Figure 1 Research Design
Figure 2 Key Data From Secondary Sources
Figure 3 Key Data From Primary Sources
Figure 4 Global Biobanking Market: Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Market, By Product & Service, 2017 vs 2022 (USD Billion)
Figure 8 Global Market, By Sample Type, 2017 vs 2022 (USD Billion)
Figure 9 Global Market, By Storage Type, 2017 vs 2022 (USD Billion)
Figure 10 Global Market, By Application, 2017 vs 2022 (USD Billion)
Figure 11 Global Market, By Region, 2017 vs 2022 (USD Billion)
Figure 12 Increase in Genomic Research Activities and the Need for Cost-Efficient Drug Discovery Driving the Biobanking Market
Figure 13 North America Held the Largest Market Share in 2017
Figure 14 Equipment Segment to Record Highest CAGR, 2017-2022
Figure 15 APAC to Register the Highest CAGR, 2017-2022
Figure 16 Biobanking Market Drivers, Restraints, Opportunities, and Challenges
Figure 17 Equipment Segment to Lead Global Biobanking Products & Services Market, 2017-2022 (USD Million)
Figure 18 Storage Equipment Segment to Lead Biobanking Equipment Market, 2017–2022 (USD Million)
Figure 19 Blood Products Segment to Lead Global Biobanking Samples Market, 2017-2022 (USD Million)
Figure 20 Manual Segment to Lead Global Biobanking Storage Market, 2017-2022 (USD Million)
Figure 21 Regenerative Medicine Segment to Lead Global Biobanking Applications Market, 2017-2022 (USD Million)
Figure 22 APAC to Register Highest CAGR, 2017-2022 (USD Million)
Figure 23 North America: Biobanking Market Snapshot
Figure 24 Equipment Segment to Lead U.S. Biobanking Products & Services Market, 2017-2022 (USD Million)
Figure 25 Europe: Market Snapshot
Figure 26 Blood Products Segment to Record Highest CAGR in German Biobanking Samples Market, 2017-2022 (USD Million)
Figure 27 APAC: Biobanking Market Snapshot
Figure 28 RoW: Biobanking Market Snapshot
Figure 29 Global Biobanking Market: Market Share (2016)
Figure 30 Biobanking Market (Global) Competitive Leadership Mapping, 2017
Figure 31 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 32 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 33 Qiagen N.V.: Company Snapshot (2016)
Figure 34 Merck KGaA: Company Snapshot (2016)
Figure 35 Vwr Corporation: Company Snapshot (2016)
Figure 36 Tecan Trading AG.: Company Snapshot (2016)
Figure 37 Brooks Automation, Inc.: Company Snapshot (2016)
Figure 38 Chart Industries, Inc.: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 1224
Published ON
Aug, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biobanking Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved